Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 276

1.

Jarle Tor Rørvik.

Myhr KM, Skei J, Gilja OH, Hove L, Gilhus NE, Bakke P.

Tidsskr Nor Laegeforen. 2018 May 8. doi: 10.4045/tidsskr.18.0260. [Epub ahead of print] Norwegian. No abstract available.

PMID:
29737765
Free Article
2.

HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis.

Hong Y, Li HF, Romi F, Skeie GO, Gilhus NE.

Acta Neurol Scand. 2018 May 7. doi: 10.1111/ane.12951. [Epub ahead of print]

PMID:
29736936
3.

The effect of parity on risk of complications in pregnant women with epilepsy: a population-based cohort study.

Danielsson KC, Borthen I, Gilhus NE, Morken NH.

Acta Obstet Gynecol Scand. 2018 May 2. doi: 10.1111/aogs.13360. [Epub ahead of print]

PMID:
29719929
4.

Hypertensive pregnancy complications in women with epilepsy and antiepileptic drugs: a population-based cohort study of first pregnancies in Norway.

Danielsson KC, Borthen I, Morken NH, Gilhus NE.

BMJ Open. 2018 Apr 24;8(4):e020998. doi: 10.1136/bmjopen-2017-020998.

5.

Young people with epilepsy have an increased risk of eating disorder and poor quality diet.

Kolstad E, Bjørk M, Gilhus NE, Alfstad K, Clench-Aas J, Lossius M.

Epilepsia Open. 2017 Dec 18;3(1):40-45. doi: 10.1002/epi4.12089. eCollection 2018 Mar.

6.

Myasthenia gravis and infectious disease.

Gilhus NE, Romi F, Hong Y, Skeie GO.

J Neurol. 2018 Jun;265(6):1251-1258. doi: 10.1007/s00415-018-8751-9. Epub 2018 Jan 25. Review.

PMID:
29372387
7.

Cognitive dysfunction after generalized tonic-clonic status epilepticus in adults.

Power KN, Gramstad A, Gilhus NE, Hufthammer KO, Engelsen BA.

Acta Neurol Scand. 2018 Apr;137(4):417-424. doi: 10.1111/ane.12898. Epub 2018 Jan 14.

PMID:
29333611
8.

Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero.

Bjørk M, Riedel B, Spigset O, Veiby G, Kolstad E, Daltveit AK, Gilhus NE.

JAMA Neurol. 2018 Feb 1;75(2):160-168. doi: 10.1001/jamaneurol.2017.3897.

PMID:
29279889
9.

Cognitive function after status epilepticus versus after multiple generalized tonic-clonic seizures.

Power KN, Gramstad A, Gilhus NE, Hufthammer KO, Engelsen BA.

Epilepsy Res. 2018 Feb;140:39-45. doi: 10.1016/j.eplepsyres.2017.11.014. Epub 2017 Nov 28.

PMID:
29227799
10.

Eculizumab: a treatment option for mysthenia gravis?

Gilhus NE.

Lancet Neurol. 2017 Dec;16(12):947-948. doi: 10.1016/S1474-4422(17)30363-0. Epub 2017 Oct 20. No abstract available. Erratum in: Lancet Neurol. 2018 Jan;17 (1):26.

PMID:
29066164
11.

[Does the mandatory special assignment in the medical education have an impact on future career choices?]

Kolstad E, Salomon-Johannessen EE, Owe JF, Gilhus NE.

Tidsskr Nor Laegeforen. 2017 Aug 21;137(14-15). doi: 10.4045/tidsskr.16.0598. Print 2017 Aug 22. Norwegian.

12.

Pathophysiology and immunological profile of myasthenia gravis and its subgroups.

Romi F, Hong Y, Gilhus NE.

Curr Opin Immunol. 2017 Dec;49:9-13. doi: 10.1016/j.coi.2017.07.006. Epub 2017 Aug 4. Review.

PMID:
28780294
13.

Multiple antibody detection in 'seronegative' myasthenia gravis patients.

Hong Y, Zisimopoulou P, Trakas N, Karagiorgou K, Stergiou C, Skeie GO, Hao HJ, Gao X, Owe JF, Zhang X, Yue YX, Romi F, Wang Q, Li HF, Gilhus NE, Tzartos SJ.

Eur J Neurol. 2017 Jun;24(6):844-850. doi: 10.1111/ene.13300. Epub 2017 May 4.

PMID:
28470860
14.

Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms.

Hong Y, Skeie GO, Zisimopoulou P, Karagiorgou K, Tzartos SJ, Gao X, Yue YX, Romi F, Zhang X, Li HF, Gilhus NE.

J Neurol. 2017 May;264(5):955-962. doi: 10.1007/s00415-017-8478-z. Epub 2017 Mar 31.

PMID:
28364296
15.

Myasthenia Gravis.

Gilhus NE.

N Engl J Med. 2017 Mar 30;376(13):e25. doi: 10.1056/NEJMc1701027. No abstract available.

16.

Myasthenia Gravis.

Gilhus NE.

N Engl J Med. 2016 Dec 29;375(26):2570-2581. doi: 10.1056/NEJMra1602678. Review. No abstract available.

PMID:
28029925
17.

Overweight in epilepsy as a risk factor for pregnancy and delivery complications.

Kolstad E, Veiby G, Gilhus NE, Bjørk M.

Epilepsia. 2016 Nov;57(11):1849-1857. doi: 10.1111/epi.13573. Epub 2016 Oct 13.

18.

Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients.

Hong Y, Li HF, Skeie GO, Romi F, Hao HJ, Zhang X, Gao X, Owe JF, Gilhus NE.

J Neuroimmunol. 2016 Sep 15;298:51-7. doi: 10.1016/j.jneuroim.2016.07.001. Epub 2016 Jul 2.

PMID:
27609275
19.

Life satisfaction in women with epilepsy during and after pregnancy.

Reiter SF, Bjørk MH, Daltveit AK, Veiby G, Kolstad E, Engelsen BA, Gilhus NE.

Epilepsy Behav. 2016 Sep;62:251-7. doi: 10.1016/j.yebeh.2016.06.025. Epub 2016 Aug 9.

PMID:
27513352
20.

Prognostic factors of status epilepticus in adults.

Power KN, Gramstad A, Gilhus NE, Engelsen BA.

Epileptic Disord. 2016 Sep 1;18(3):297-304. doi: 10.1684/epd.2016.0855.

21.

Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis.

Li HF, Hong Y, Zhang X, Xie Y, Skeie GO, Hao HJ, Gilhus NE, Liang B, Yue YX, Zhang XJ, Gao X, Wang Q, Gao Z, Ding XJ, Song M.

Mol Neurobiol. 2017 Aug;54(6):4771-4780. doi: 10.1007/s12035-016-0024-y. Epub 2016 Aug 8.

PMID:
27501803
22.

Health and social conditions in Norwegian polio survivors: A 20-year follow-up study.

Festvåg L, Schanke AK, Gilhus NE, Aarrestad S, Lofthus K, Johnsen S, Strømsholm G, Øyhaugen S, Hartviksen RS, Stanghelle JK.

J Rehabil Med. 2016 Oct 5;48(8):688-695. doi: 10.2340/16501977-2118.

23.

[Myasthenia gravis - optimal treatment and accurate diagnosis].

Gilhus NE, Kerty E, Løseth S, Mygland Å, Tallaksen C.

Tidsskr Nor Laegeforen. 2016 Jul 5;136(12-13):1089-94. doi: 10.4045/tidsskr.15.1259. eCollection 2016 Jul. Review. Norwegian.

24.

Does the choice of antiepileptic drug affect survival in glioblastoma patients?

Knudsen-Baas KM, Engeland A, Gilhus NE, Storstein AM, Owe JF.

J Neurooncol. 2016 Sep;129(3):461-469. doi: 10.1007/s11060-016-2191-0. Epub 2016 Jul 4.

PMID:
27377653
25.

Status epilepticus secondary to glioma.

Knudsen-Baas KM, Power KN, Engelsen BA, Hegrestad SE, Gilhus NE, Storstein AM.

Seizure. 2016 Aug;40:76-80. doi: 10.1016/j.seizure.2016.06.013. Epub 2016 Jun 23.

26.

International consensus guidance for management of myasthenia gravis: Executive summary.

Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M, Palace J, Richman DP, Verschuuren J, Narayanaswami P.

Neurology. 2016 Jul 26;87(4):419-25. doi: 10.1212/WNL.0000000000002790. Epub 2016 Jun 29. Review.

27.

Factors affecting outcome in myasthenia gravis.

Andersen JB, Gilhus NE, Sanders DB.

Muscle Nerve. 2016 Dec;54(6):1041-1049. doi: 10.1002/mus.25205.

PMID:
27251303
28.

Myasthenia gravis - autoantibody characteristics and their implications for therapy.

Gilhus NE, Skeie GO, Romi F, Lazaridis K, Zisimopoulou P, Tzartos S.

Nat Rev Neurol. 2016 May;12(5):259-68. doi: 10.1038/nrneurol.2016.44. Epub 2016 Apr 22. Review.

PMID:
27103470
29.

Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap.

Gotaas HT, Skeie GO, Gilhus NE.

Neuromuscul Disord. 2016 Jun;26(6):337-41. doi: 10.1016/j.nmd.2016.03.003. Epub 2016 Mar 28.

PMID:
27102003
30.

Myasthenia gravis: subgroup classifications - Authors' reply.

Gilhus NE, Verschuuren JJ.

Lancet Neurol. 2016 Apr;15(4):357-8. doi: 10.1016/S1474-4422(16)00035-1. No abstract available.

PMID:
26971656
31.

Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen.

Stergiou C, Lazaridis K, Zouvelou V, Tzartos J, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Behin A, Sharshar T, De Baets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen C, Maniaol A, Gilhus NE, Casasnovas Pons C, Pitha J, Jakubíkova M, Hanisch F, Bogomolovas J, Labeit D, Labeit S, Tzartos SJ.

J Neuroimmunol. 2016 Mar 15;292:108-15. doi: 10.1016/j.jneuroim.2016.01.018. Epub 2016 Jan 27.

PMID:
26943968
32.

Psychiatric Comorbidity, Social Aspects and Quality of Life in a Population-Based Cohort of Expecting Fathers with Epilepsy.

Reiter SF, Veiby G, Bjørk MH, Engelsen BA, Daltveit AK, Gilhus NE.

PLoS One. 2015 Dec 4;10(12):e0144159. doi: 10.1371/journal.pone.0144159. eCollection 2015.

33.

Response to 'Outcome prediction and reporting in nonconvulsive status epilepticus'.

Power KN, Gramstad A, Gilhus NE, Engelsen BA.

Seizure. 2015 Dec;33:100. doi: 10.1016/j.seizure.2015.08.006. Epub 2015 Aug 29. No abstract available.

34.

Myasthenia gravis: subgroup classification and therapeutic strategies.

Gilhus NE, Verschuuren JJ.

Lancet Neurol. 2015 Oct;14(10):1023-36. doi: 10.1016/S1474-4422(15)00145-3. Review.

PMID:
26376969
35.

Treatment for postpolio syndrome.

Koopman FS, Beelen A, Gilhus NE, de Visser M, Nollet F.

Cochrane Database Syst Rev. 2015 May 18;(5):CD007818. doi: 10.1002/14651858.CD007818.pub3. Review.

PMID:
25984923
36.

Complicating autoimmune diseases in myasthenia gravis: a review.

Nacu A, Andersen JB, Lisnic V, Owe JF, Gilhus NE.

Autoimmunity. 2015;48(6):362-8. doi: 10.3109/08916934.2015.1030614. Epub 2015 Apr 27. Review.

37.

Epilepsy and recommendations for breastfeeding.

Veiby G, Bjørk M, Engelsen BA, Gilhus NE.

Seizure. 2015 May;28:57-65. doi: 10.1016/j.seizure.2015.02.013. Epub 2015 Mar 16. Review.

38.

Epilepsy and eating disorders during pregnancy: Prevalence, complications and birth outcome.

Kolstad E, Gilhus NE, Veiby G, Reiter SF, Lossius MI, Bjørk M.

Seizure. 2015 May;28:81-4. doi: 10.1016/j.seizure.2015.02.014. Epub 2015 Feb 21.

39.

Depression and anxiety during pregnancy and the postpartum period in women with epilepsy: A review of frequency, risks and recommendations for treatment.

H Bjørk M, Veiby G, A Engelsen B, Gilhus NE.

Seizure. 2015 May;28:39-45. doi: 10.1016/j.seizure.2015.02.016. Epub 2015 Feb 21. Review.

40.

Depression and anxiety in women with epilepsy during pregnancy and after delivery: a prospective population-based cohort study on frequency, risk factors, medication, and prognosis.

Bjørk MH, Veiby G, Reiter SC, Berle JØ, Daltveit AK, Spigset O, Engelsen BA, Gilhus NE.

Epilepsia. 2015 Jan;56(1):28-39. doi: 10.1111/epi.12884. Epub 2014 Dec 19.

41.

Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development.

Heldal AT, Eide GE, Romi F, Owe JF, Gilhus NE.

PLoS One. 2014 Dec 2;9(12):e114060. doi: 10.1371/journal.pone.0114060. eCollection 2014.

42.

Adult nonconvulsive status epilepticus in a clinical setting: Semiology, aetiology, treatment and outcome.

Power KN, Gramstad A, Gilhus NE, Engelsen BA.

Seizure. 2015 Jan;24:102-6. doi: 10.1016/j.seizure.2014.09.007. Epub 2014 Oct 2. Erratum in: Seizure. 2015 Dec;33:103.

43.

Myasthenia gravis and risks for comorbidity.

Gilhus NE, Nacu A, Andersen JB, Owe JF.

Eur J Neurol. 2015 Jan;22(1):17-23. doi: 10.1111/ene.12599. Epub 2014 Oct 30. Review.

PMID:
25354676
44.

Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.

Wolff AS, Kärner J, Owe JF, Oftedal BE, Gilhus NE, Erichsen MM, Kämpe O, Meager A, Peterson P, Kisand K, Willcox N, Husebye ES.

J Immunol. 2014 Oct 15;193(8):3880-90. doi: 10.4049/jimmunol.1401068. Epub 2014 Sep 17.

45.

Antititin antibody in early- and late-onset myasthenia gravis.

Szczudlik P, Szyluk B, Lipowska M, Ryniewicz B, Kubiszewska J, Dutkiewicz M, Gilhus NE, Kostera-Pruszczyk A.

Acta Neurol Scand. 2014 Oct;130(4):229-33. doi: 10.1111/ane.12271. Epub 2014 Jun 20.

PMID:
24947881
46.

Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study.

Andersen JB, Owe JF, Engeland A, Gilhus NE.

Eur J Neurol. 2014 Jul;21(7):948-55. doi: 10.1111/ene.12439. Epub 2014 Apr 9.

47.

Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries.

Andersen JB, Heldal AT, Engeland A, Gilhus NE.

Acta Neurol Scand Suppl. 2014;(198):26-31. doi: 10.1111/ane.12233.

PMID:
24588503
48.

Neurological disorders in the Global Burden of Disease 2010 study.

Stovner LJ, Hoff JM, Svalheim S, Gilhus NE.

Acta Neurol Scand Suppl. 2014;(198):1-6. doi: 10.1111/ane.12229.

PMID:
24588499
49.

EFNS/ENS Guidelines for the treatment of ocular myasthenia.

Kerty E, Elsais A, Argov Z, Evoli A, Gilhus NE.

Eur J Neurol. 2014 May;21(5):687-93. doi: 10.1111/ene.12359. Epub 2014 Jan 28. Review.

PMID:
24471489
50.

Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy.

Veiby G, Daltveit AK, Engelsen BA, Gilhus NE.

J Neurol. 2014 Mar;261(3):579-88. doi: 10.1007/s00415-013-7239-x. Epub 2014 Jan 22.

PMID:
24449062

Supplemental Content

Loading ...
Support Center